| Serial Number | 79345734 |
| Word Mark | C CENYX BIOTECH |
| Filing Date | Friday, April 29, 2022 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, March 26, 2024 |
| Registration Number | 7333762 |
| Registration Date | Tuesday, March 26, 2024 |
| Mark Drawing | 5 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | Tuesday, January 9, 2024 |
| Description of Mark | The mark consists of the following: a stylized letter "C" in the colors purple, green, blue-green, and teal. The wording "CENYX" appears in navy blue stylized font, and further below is the wording "BIOTECH" in blue-green stylized font. |
| Description of the Colors Claimed | The color purple, blue-green, teal, emerald and navy are harmonized in C-shaped letter. The color navy appears in the word CENYX and the color blue-green appears in the word BIOTECH. |
| Goods and Services | Diagnostic reagents for medical or veterinary purposes; diagnostic preparations for medical or veterinary purposes; veterinary preparations for the treatment of infectious and parasitic diseases, neoplasms, diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism, endocrine, nutritional and metabolic diseases, mental and behavioural disorders, diseases of the nervous system, diseases of the eye and adnexa, diseases of the ear and mastoid process, diseases of the circulatory system, diseases of the respiratory system, diseases of the digestive system, diseases of the skin and subcutaneous tissue, diseases of the musculoskeletal system and connective tissue, diseases of the genitourinary system, congenital malformations, deformations and chromosomal abnormalities, or injury, poisoning and certain other consequences of external causes for animal and poultry; radio-isotope markers for therapeutic or diagnostic use; in vitro diagnostic preparations for medical purposes; vaccines; contrast media for use in medical imaging equipment; contrast media for in vivo imaging; drug delivery agents in the form of compounds, wrapping wafers, edible wafers that facilitate the delivery of pharmaceutical preparations; pharmaceutical preparations for the prevention of inflammatory disorders; non-prescription medicines, namely, medicinal preparations in the nature of pills, tablets, capsules, caplets, liquid drops, sachets, oral liquids, suspensions, liquids, semi-solids, creams, syrups, ointments, lotions, gels, sprays, emulations, oils, pessaries, suppositories, granules and films for the treatment of infectious and parasitic diseases, neoplasms, diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism, endocrine, nutritional and metabolic diseases, mental and behavioural disorders, diseases of the nervous system, diseases of the eye and adnexa, diseases of the ear and mastoid process, diseases of the circulatory system, diseases of the respiratory system, diseases of the digestive system, diseases of the skin and subcutaneous tissue, diseases of the musculoskeletal system and connective tissue, diseases of the genitourinary system, congenital malformations, deformations and chromosomal abnormalities, or injury, poisoning and certain other consequences of external causes; radioactive pharmaceutical preparations for use in vivo diagnostics or therapeutic use; diagnostic agents for medical purposes; biological preparations for medical purposes, namely, biological preparations for the treatment of infectious and parasitic diseases, neoplasms, diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism, endocrine, nutritional and metabolic diseases, mental and behavioural disorders, diseases of the nervous system, diseases of the eye and adnexa, diseases of the ear and mastoid process, diseases of the circulatory system, diseases of the respiratory system, diseases of the digestive system, diseases of the skin and subcutaneous tissue, diseases of the musculoskeletal system and connective tissue, diseases of the genitourinary system, congenital malformations, deformations and chromosomal abnormalities, or injury, poisoning and certain other consequences of external causes for medical or veterinary purposes; pharmaceuticals for the treatment of infectious and parasitic diseases, neoplasms, diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism, endocrine, nutritional and metabolic diseases, mental and behavioural disorders, diseases of the nervous system, diseases of the eye and adnexa, diseases of the ear and mastoid process, diseases of the circulatory system, diseases of the respiratory system, diseases of the digestive system, diseases of the skin and subcutaneous tissue, diseases of the musculoskeletal system and connective tissue, diseases of the genitourinary system, congenital malformations, deformations and chromosomal abnormalities, or injury, poisoning and certain other consequences of external causes; pharmaceutical preparations for the prevention of disorders of the cardio-vascular system; pharmaceutical preparations for the treatment of cardiovascular disease; drug delivery agents in the form of tablets or capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; pharmaceutical preparations for the treatment of inflammatory diseases; antibodies for medical purposes |
| Indication of Colors claimed | The color(s) purple, blue-green, teal, green, and navy blue is/are claimed as a feature of the mark. |
| NOT AVAILABLE | "BIOTECH" |
| Goods and Services | Scientific research in the nature of conducting clinical trials for others in the field of cardiovascular disease; scientific research for medical purposes in the field of cancerous diseases; pharmaceutical research and development; Scientific research in the nature of conducting clinical trials for others in the field of medicine; analysis, and evaluation of medical product development services of others to assure compliance with industry standards; scientific research for medical purposes in the area of cancerous diseases; scientific research in the field of pharmacy |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, July 22, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, July 22, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Cenyx Biotech Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | KR |
| Party Name | Cenyx Biotech Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | KR |
| Party Name | Cenyx Biotech Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | KR |
| Event Date | Event Description |
| Friday, July 22, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, July 21, 2022 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Tuesday, July 26, 2022 | APPLICATION FILING RECEIPT MAILED |
| Friday, February 17, 2023 | ASSIGNED TO EXAMINER |
| Wednesday, March 8, 2023 | NON-FINAL ACTION WRITTEN |
| Thursday, March 9, 2023 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Thursday, April 27, 2023 | REFUSAL PROCESSED BY MPU |
| Thursday, April 27, 2023 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Wednesday, May 17, 2023 | REFUSAL PROCESSED BY IB |
| Tuesday, October 24, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, October 24, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, October 24, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Sunday, November 5, 2023 | ASSIGNED TO EXAMINER |
| Tuesday, November 7, 2023 | ASSIGNED TO EXAMINER |
| Wednesday, November 29, 2023 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, November 29, 2023 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, November 29, 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, November 29, 2023 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, November 29, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, December 20, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, December 20, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, December 20, 2023 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, December 27, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Monday, January 8, 2024 | NOTIFICATION PROCESSED BY IB |
| Tuesday, January 9, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, January 9, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, March 26, 2024 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, March 26, 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Thursday, June 27, 2024 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Saturday, January 13, 2024 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Wednesday, December 27, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |